Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cognito Therapeutics
Biotech
Neumora overhauls C-suite after phase 3 flop—Chutes & Ladders
Neumora overhauls C-suite after phase 3 flop. Lycia lands veteran CMO. Navigator arrives at new CEO.
Darren Incorvaia
,
Zoey Becker
Feb 14, 2025 8:30am
Cell-focused Sana scoops first CSO—Chutes & Ladders
Aug 30, 2024 8:30am
Cognito opens biomarker study of neuromod device in Alzheimer’s
Jan 23, 2024 10:45am
Cognito study shows white matter growth after neuromod treatment
Dec 12, 2023 10:44am
Longtime BioMarin CEO hands off baton—Chutes & Ladders
Nov 3, 2023 9:30am
Cognito taps former BrainStorm president as medical chief
Apr 17, 2023 11:15am
